The risk of myocarditis in children, inside CMS' 1,394-page outpatient final rule, and more.

The 5 most important considerations about vaccines for kids (Monday, Nov. 1)

Covid-19 vaccines for children aged 5-11 are coming. As we move forward to the next step of fighting the pandemic, it can be easy to feel lost in a wave of approvals, changing guidelines, and differing public opinion. But according to Advisory Board's Pamela Divack and Andrew Mohama, the most important factors for you to consider in this newest approval can be boiled down to five key points.

Steve Klasko on diverging from the 'natural order of things' to move health care forward (Tuesday, Nov. 2)

In this edition of "Lessons from the C-suite," Steve Klasko, CEO of Jefferson Health, talks with Advisory Board President Eric Larsen about revelations in a Barnes & Noble, navigating "principled" growth, and how he approaches health care through an "old math versus new math" mindset.

Inside CMS' 1,394-page outpatient final rule (Wednesday, Nov. 3)

CMS on Tuesday released the highly anticipated final rule for hospital outpatient departments and ambulatory surgical centers for calendar year 2022. Advisory Board's Heather Bell pulled out the most notable policies coming your way on January 1—including fines of up to $2 million for price transparency non-compliance—and what they mean for providers.

What the data says about the risk of myocarditis in children (Thursday, Nov. 4)

Research has found that children are at an elevated risk of developing myocarditis, an inflammation of the heart muscle, after receiving an mRNA Covid-19 vaccine. But experts say that risk is small and the condition is temporary—and the risk of Covid-19 damaging the heart is much bigger.

The Covid-19 vaccine mandate: Here's what in CMS' new rule (Friday, Nov. 5)

On Thursday, CMS issued an interim final rule requiring most health care facilities that participate in Medicare and Medicaid programs to have their staff fully vaccinated against Covid-19 by January 4, 2022. Advisory Board's Heather Bell and Carol Boston-Fleischhauer outline the new requirements—and how health care executives should respond.